Predictive Value of New AMH Test Method for Ovarian Response
Predictive Value of New AMH Test Method for Ovarian Response in Patients With IVF/ICSI
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410008
- Reproductive & Genetic hospital Of CITIC-Xiangya
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The first IVF/ICSI COH cycle;
- the causes of infertility :fallopian tube factors and/or male factors;
Exclusion Criteria:
- Endometriosis;
- PCOS;
- Adenomyosis;
- PGT cycle because of the female chromosome abnormality or genetic abnormality;
- FET cycle;
- Malignant tumor patient.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ELISA
ELISA kit detecting the serum AMH level
|
ELISA kit detecting the serum AMH level
Other Names:
|
|
Chemiluminescence
CLIA method detecting the serum AMH level
|
CLIA method detecting the serum AMH level
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the AMH(CLIA) cutoff value of low and high ovarian response
Time Frame: the day of oocytes retrieved,about three months after AMH test
|
the poor ovarian response :the number of retrieved oocyte ≤ 3,the high ovarian response :the number of retrieved oocyte ≥ 15
|
the day of oocytes retrieved,about three months after AMH test
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of oocytes retrieved
Time Frame: 34-36 hours after hCG trigger,about three months after AMH test
|
the number of oocytes retrieved after hCG trigger
|
34-36 hours after hCG trigger,about three months after AMH test
|
|
the serum AMH level
Time Frame: any day of the menstrual cycle, about three months after study starting
|
anti-muller hormone
|
any day of the menstrual cycle, about three months after study starting
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Fei Gong, PhD, Reproductive & Genetic hospital Of CITIC-Xiangya
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- P2020004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.